Skip to content

Avalyn Pharma

US · AVLN #3161 by market cap Listed 2026
28.40 -0.30 -1.05%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 28.37 -1.15%
After-hours 28.40 0.00%
39.2523.3328.402026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on AVLN?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -23.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has risen to 5.2% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is above its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Performance

1W -6.21%
1M +15.31%
3M -23.51%
6M +1.32%

Key statistics

Price & volume

Prev close
28.70
Open
28.06
Day range
27.85 - 29.38
Avg price
28.50
Volume
214.30K
Turnover
6.11M
Amplitude
5.35%
52-week range
22.24 - 40.17

Valuation

P/E
-13.94
P/E (TTM)
-11.53
P/B
3.42
EPS
-2.04
Net profit
-90.73M
Net assets
370.24M

Share structure

Market cap
1.26B
Float cap
861.00M
Shares out
44.52M
Float shares
30.32M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2026-04-30
52-week range 34% of range
22.24 40.17

29.3% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-2.32M net over the window

Short interest

Shares short
2.30M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Avalyn Pharma (AVLN)?

Avalyn Pharma last traded at 28.40. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Avalyn Pharma's market cap?

About 1.26B.

What is the P/E ratio of Avalyn Pharma?

The trailing twelve-month P/E is -11.53. The Valuation tab shows it against the stock's own five-year range.

Does Avalyn Pharma pay a dividend?

Avalyn Pharma does not currently pay a regular dividend.

Is Avalyn Pharma a buy according to analysts?

The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 60.00, which implies 111.3% upside from the current price. This is not investment advice.

What is Avalyn Pharma's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Avalyn Pharma a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Avalyn Pharma discussion 0 comments

Add a comment